文献速递脑血管病神经重症与神经感染

城市与非城市地区分诊的疑似大血管闭塞卒中患者的工作流程与结局

Workflows and Outcomes in Patients With Suspected Large Vessel Occlusion Stroke Triaged in Urban and Nonurban Areas.
PubMed 文献 · Stroke · 2022-10-19

研究比较了RACECAT试验期间西班牙加泰罗尼亚地区城市(转诊中心可取栓)与非城市地区疑似大血管闭塞卒中患者(Rapid Arterial Occlusion Evaluation评分≥5)的结局。倾向评分匹配后,非城市地区缺血性卒中患者90天改良Rankin量表评分更高(共同OR 1.25,95%CI 1.06-1.48),差异仅见于大血管闭塞患者(共同OR 1.36,95%CI 1.08-1.65);两组死亡率相似(OR 1.02,95%CI 0.81-1.28)。非城市地区患者接受溶栓的比值更高(OR 1.36,95%CI 1.16-1.67),接受取栓的比值更低(OR 0.61,95%CI 0.51-0.75),且发病至溶栓和取栓的时间更长。

要点

  • 非城市地区缺血性卒中患者90天改良Rankin量表评分更高(共同OR 1.25,95%CI 1.06-1.48)。
  • 残疾差异仅见于大血管闭塞患者(共同OR 1.36,95%CI 1.08-1.65)。
  • 非城市地区患者接受溶栓的比值更高(OR 1.36),接受取栓的比值更低(OR 0.61)。

核心结论

  • 在西班牙加泰罗尼亚,非城市地区分诊的大血管闭塞卒中患者神经功能结局差于城市地区(转诊中心可取栓)患者。
  • 作者建议应致力于改善组织实践并在偏远地区中心发展取栓能力。

研究设计与样本

  • 研究纳入RACECAT试验入组期间加泰罗尼亚卒中代码登记中,来自可取栓中心城市集水区、Rapid Arterial Occlusion Evaluation评分≥5的疑似大血管闭塞卒中患者。
  • 分析纳入非城市地区1369例患者和城市地区2502例患者,并基于倾向评分匹配了920例城市与非城市地区缺血性卒中患者。

主要发现

  • 非城市地区缺血性卒中患者90天改良Rankin量表评分中位数3(四分位距2-5),城市地区为3(1-5),共同OR 1.25(95%CI 1.06-1.48)。
  • 上述平均效应仅在大血管闭塞患者中显著(共同OR 1.36,95%CI 1.08-1.65)。
  • 两组死亡率相似(OR 1.02,95%CI 0.81-1.28)。
  • 非城市地区患者接受溶栓的比值更高(OR 1.36,95%CI 1.16-1.67),接受取栓的比值更低(OR 0.61,95%CI 0.51-0.75)。
  • 非城市地区患者发病至溶栓时间更长(平均差38分钟,95%CI 25-52),发病至取栓时间更长(平均差66分钟,95%CI 37-95)。

临床怎么用

  • 作者认为应致力于改善组织实践并在偏远地区中心发展取栓能力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We aim to compare the outcome of patients from urban areas, where the referral center is able to perform thrombectomy, with patients from nonurban areas enrolled in the RACECAT trial (Direct Transfer to an Endovascular Center Compared to Transfer to the Closest Stroke Center in Acute Stroke Patients With Suspected Large Vessel Occlusion). METHODS: Patients with suspected large vessel occlusion stroke, as evaluated by a Rapid Arterial Occlusion Evaluation score of ≥5, from urban catchment areas of thrombectomy-capable centers during RACECAT trial enrollment period were included in the Stroke Code Registry of Catalonia. Primary outcome was disability at 90 days, as assessed by the shift analysis on the modified Rankin Scale score, in patients with an ischemic stroke. Secondary outcomes included mortality at 90 days, rate of thrombolysis and thrombectomy, time from onset to thrombolysis, and thrombectomy initiation. Propensity score matching was used to assemble a cohort of patients with similar characteristics. RESULTS: The analysis included 1369 patients from nonurban areas and 2502 patients from urban areas. We matched 920 patients with an ischemic stroke from urban areas and nonurban areas based on their propensity scores. Patients with ischemic stroke from nonurban areas had higher degrees of disability at 90 days (median [interquartle range] modified Rankin Scale score, 3 [2-5] versus 3 [1-5], common odds ratio, 1.25 [95% CI, 1.06-1.48]); the observed average effect was only significant in patients with large vessel stroke (common odds ratio, 1.36 [95% CI, 1.08-1.65]). Mortality rate was similar between groups(odds ratio, 1.02 [95% CI, 0.81-1.28]). Patients from nonurban areas had higher odds of receiving thrombolysis (odds ratio, 1.36 [95% CI, 1.16-1.67]), lower odds of receiving thrombectomy(odds ratio, 0.61 [95% CI, 0.51-0.75]), and longer time from stroke onset to thrombolysis (mean difference 38 minutes [95% CI, 25-52]) and thrombectomy(mean difference 66 minutes [95% CI, 37-95]). CONCLUSIONS: In Catalonia, Spain, patients with large vessel occlusion stroke triaged in nonurban areas had worse neurological outcomes than patients from urban areas, where the referral center was able to perform thrombectomy. Interventions aimed at improving organizational practices and the development of thrombectomy capabilities in centers located in remote areas should be pursued. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT02795962.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Garcia-Tornel A, Millan M, Rubiera M, et al. Workflows and Outcomes in Patients With Suspected Large Vessel Occlusion Stroke Triaged in Urban and Nonurban Areas. Stroke. 2022. PMID: 36259411. doi:10.1161/STROKEAHA.122.040768

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。